Home > Insider Trading > Valeant Pharmaceuticals International

Valeant Pharmaceuticals International (VRX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
201 - 210
Next >>

Is Zoetis Inc (ZTS) Bill Ackman's Back-up Plan for Valeant Pharmaceuticals Intl Inc (VRX)?

As it was previously rumored in many sources, Bill Ackman's Pershing Square took a massive position in Zoetis Inc (NYSE:ZTS), as reported in a new filing with the US Securities and Exchange Commission...

Keep Reading →

November 12th, 2014 - Hedge Funds News

Allergan, Inc. (AGN): Bill Ackman Sends Letter Commenting on Potential Merger Deal with Actavis plc (ACT)

Bill Ackman's intentions to acquire Allergan, Inc. (NYSE:AGN) together with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) might be a wasted exercise as the former is trying to shun the deal.

Keep Reading →

November 7th, 2014 - Hedge Funds News

Allergan Inc. (AGN) Push For Actavis plc (ACT) Merger Shunning Valeant Pharmaceuticals Intl Inc. (VRX) Hostile Bid

Bill Ackman may be failing all together on his push to get Allergan to agree to a merger agreement with Valeant Pharmaceuticals Intl Inc. (NYSE:VRX).

Keep Reading →

November 7th, 2014 - News

Hedge Fund News: Nelson Peltz, Jim Chanos & Warren Buffett

The Madison Square Garden Company surprised many on Monday when it announced — besides exploring a potential breakup of itself — that it was adding two financiers to its board, one being the activist...

Keep Reading →

October 28th, 2014 - Hedge Funds

Hedge Fund News: Bill Ackman, Christian Leone & Valueact Capital

Bill Ackman wants to clear up a few things. First, the activist investor and CEO of Pershing Square Capital Management LP is not a fan of “hostile” to describe unsolicited takeover offers.

Keep Reading →

October 24th, 2014 - Hedge Funds

Hedge Fund News: Steven Cohen, Carl Icahn & Lansdowne Partners

The best thing federal prosecutors might have done for Steven A.

Keep Reading →

October 16th, 2014 - Hedge Funds

Valeant Pharmaceuticals Intl Inc (VRX): ValueAct Capital Raises Stake as Jeffrey Ubben is Appointed as Board Director

Jeffrey Ubben’s Valueact Capital Management disclosed today an increase in its exposure to Valeant Pharmaceuticals Intl Inc (NYSE:VRX).

Keep Reading →

September 25th, 2014 - Hedge Funds News

Hedge Fund News: Marc Lasry, Warren Buffett & Marcato Capital Management

Avenue Capital Group LLC, the U.S.

Keep Reading →

September 23rd, 2014 - Hedge Funds

Allergan Inc. (AGN) Settles Lawsuit with Pershing Square, Valeant Pharmaceuticals Intl Inc (VRX); Agrees on Calling Special Shareholders Meeting

Pershing Square, managed by Bill Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) have entered into an agreement with Allergan Inc.

Keep Reading →

September 17th, 2014 - Hedge Funds News

Hedge Fund News: Edward Lampert, George Soros & Bill Ackman

Hedge fund ESL Investments has loaned $400 million to its largest investment, Sears Holdings Corporation (NASDAQ:SHLD), a cash infusion that will keep the struggling retailer afloat through the holiday...

Keep Reading →

September 16th, 2014 - Hedge Funds